Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Migraine therapy remains suboptimal worldwide

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Migraine therapy remains suboptimal worldwide. Pharmacoecon. Outcomes News 380, 5 (2002). https://doi.org/10.1007/BF03279599

    Download citation

    Keywords

    • Migraine
    • Outcome News
    • Migraine Attack
    • Ongoing Effort
    • Triptan